Floatz logo

DEXAMETHASONE

Knee Arthritis

Poznan University of Medical SciencesSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Knee Arthritis cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BBB
NEPENTHE
Poznan University of Medical Sciences
Phase 4BB
Bxcl501
Poznan University of Medical Sciences
Phase 4BB
DEXKETOPROFEN
Poznan University of Medical Sciences
Phase 4BB
METAMIZOLE
Poznan University of Medical Sciences
Phase 4BB

View all 10 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →